Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies

    Aug 16, 2023, 08:47 AM by
    Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies Accelerating Biotech Success
    Full story
  • Nanopore Sequencing Detects Protein Structures

    Aug 16, 2023, 01:00 AM by User Not Found
    Bio-IT World | University of Oxford researchers have detected protein structure modifications using nanopore technology.
    Full story
  • SSI Strategy and NDA Group Combine to Form Best-in-Class Global Life Sciences Consultancy

    Aug 15, 2023, 09:31 AM by
    SSI Strategy has announced that it has entered into a definitive agreement to acquire NDA Group AB. This strategic combination will create a premier consultancy, specializing in guiding drug development companies from concept to commercialization.
    Full story
  • Researchers Close In On Protein Panel For Predicting Islet Autoimmunity

    Aug 15, 2023, 01:00 AM by User Not Found
    Bio-IT World | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.
    Full story
  • ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium

    Aug 11, 2023, 10:09 AM by
    Mtech Access has announced that its annual NHS Transformation Symposium, this September, will feature guest speakers Penny Dash and Paul Miller, who hold strategic leadership roles in an Integrated Care Systemand Board, respectively.
    Full story
  • Form Bio Announces First Half 2023 Achievements

    Aug 11, 2023, 10:09 AM by
    Key Partnerships, Breakthrough Technology Advancement, Key Leadership Hires, and Industry Recognition Demonstrate Strong Success
    Full story
  • RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

    Aug 11, 2023, 10:09 AM by
    RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023
    Full story
  • Phastar Appoints Graham Clark as New Chief Executive Officer

    Aug 10, 2023, 09:23 AM by
    Phastar Appoints Graham Clark as New Chief Executive Officer Phastar Sets Course for Further Growth with New CEO Appointment
    Full story
  • AI-Powered Healthcare: How Chatbots Are Transforming Healthcare

    Aug 10, 2023, 09:23 AM by
    Healthcare chatbots are set to change how we look after our health. In the future, these digital helpers will talk more like humans, making it feel like chatting with a friend. They'll learn from each conversation, offering better advice over time. These chatbots will work alongside doctors, helping screen and understand patients' problems. They'll speak many languages, team up with gadgets like smartwatches to monitor our health, and be available 24/7. Plus, they'll remind us about medicines and appointments, keep our health data safe, and even help with emotional well-being. In short, they'll make healthcare more personal, easy, and accessible for everyone.
    Full story
  • New Illumina CTO, Q2 Updates

    Aug 9, 2023, 16:53 PM by User Not Found
    Bio-IT World | Illumina today announced that Alex Aravanis, CTO, has departed Illumina to pursue an opportunity outside of the company effective immediately. In his place, Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO).
    Full story
  • Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health

    Aug 9, 2023, 09:03 AM by
    Full story
  • Recent Cash Injection Boosts VectorBuilder to Unicorn Status

    Aug 9, 2023, 09:03 AM by
    VectorBuilder's latest cash injection drives them towards a CDMO facility for the manufacturing of plasmids, mRNA, AAV, lentivirus, cell lines, and a variety of viral and non-viral vectors
    Full story
  • Huateng Pharma Develops CAS NO.156-83-2 (Minoxidil Intermediate) Against Hair Loss

    Aug 9, 2023, 09:03 AM by
    About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818
    Full story
  • ArisGlobal to Relocate Global Headquarters to Boston Area

    Aug 9, 2023, 09:03 AM by
    ArisGlobal's move to the Greater Boston area reflects growth needs and geographically positions the life sciences SaaS provider among leading biopharmaceutical organizations.
    Full story
  • Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner

    Aug 9, 2023, 01:00 AM by User Not Found
    Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
    Full story
  • Generate Biomedicines’ R&D Data Platform to Support ML-Driven Drug Discovery

    Aug 8, 2023, 01:00 AM by User Not Found
    Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”
    Full story
  • Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products

    Aug 3, 2023, 10:02 AM by
    Full story
  • Lactabico Joins Biolabs Heidelberg, Establishes EU Presence

    Aug 3, 2023, 09:29 AM by
    The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.
    Full story
  • Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

    Aug 3, 2023, 09:29 AM by
    Full story
  • An AI Tool for Lung Cancer Diagnosis in Indian Populations, Settings

    Aug 3, 2023, 01:00 AM by User Not Found
    Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.
    Full story
  • «
  • 71 (current)
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy